Up to $28.6 million in borrowing capacity through May 2029 WARREN, N.J., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Tevogen Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN), a healthcare company focused on combining biopharma, artificial intelligence, and healthcare services to improve the affordability and accessibility of life-saving medicines, has extended the end of the borrowing period under its existing loan agreement with The Patel Family, LLP from May 2027 to May 2029. The facility permits borrow
Tipranks Press Release.
Tevogen Bio Holdings (TVGN) said Wednesday it received written notice from Nasdaq on Sept. 29 confir
Detailed price information for Tevogen Inc (TVGN-Q) from The Globe and Mail including charting and trades.
This is the newest page. Registered accounts read further back.